Lung cancer risk in north Indian population: Role of genetic polymorphisms and smoking

Molecular and Cellular Biochemistry

Volumn 322, Issue 1-2, 2009, Pages 73-79

  Kumar, Munish ^a,b   Agarwal, Sudhir K ^a,b   Goel, Sudhir K ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^b UNIVERSITY OF LUCKNOW   (India)

Author keywords

CYP1A1; Genetic polymorphism; GSTM1; Lung cancer; Smoking

Indexed keywords

ADENINE; CYTOCHROME P450 1A1; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; GUANINE; VALINE;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; ATTRIBUTABLE RISK; CANCER RISK; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HIGH RISK BEHAVIOR; HUMAN; INDIAN; LUNG CANCER; LUNG CARCINOGENESIS; MAJOR CLINICAL STUDY; MALE; NULL ALLELE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SEQUENCE ANALYSIS; SMOKING HABIT;

ADULT; CYTOCHROME P-450 CYP1A1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; LUNG NEOPLASMS; MALE; POLYMORPHISM, GENETIC; RISK; SMOKING;

NICOTIANA TABACUM;

EID: 59349099010     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-008-9941-z     Document Type: Article

References (45)

1. Vineis P (2002) The relationship between polymorphisms of xenobiotic metabolizing enzymes and susceptibility to cancer. Toxicology 181:457-462. doi: 10.1016/S0300-483X(02)00450-X
2. Gonzalez FJ, Gelboin HV (1994) Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins. Drug Metab Rev 26:165-183. doi: 10.3109/03602539409029789
3. Carlsten C, Sagoo GS, Frodsham AJ, Burke W, Higgins JP (2008) Glutathione S-transferase M1 (GSTM1) polymorphisms and lung cancer: A literature-based systematic HuGE review and meta-analysis. Am J Epidemiol 167:759-774. doi: 10.1093/aje/kwm383
4. Yang M, Choi Y, Hwangbo B, Lee JS (2007) Combined effects of genetic polymorphisms in six selected genes on lung cancer susceptibility. Lung Cancer 57:135-142. doi: 10.1016/j.lungcan.2007.03.005
5. Hayashi S, Watanabe J, Nakachi K, Kawajiri K (1991) Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene. J Biochem 110:407-411
6. Pearson WR, Vorachek WR, Xu SJ, Berger R, Hart J, Vannais D, Patterson D (1993) Identification of class-mu glutathione transferase genes GSTM1-GSTM5 on human chromosome 1p13. Am J Hum Genet 53:220-233
7. Landi S (2000) Mammalian class theta GST and differential susceptibility to carcinogens: A review. Mutat Res 463:247-283. doi: 10.1016/ S1383-5742(00)00050-8
8. Kano T, Sakai M, Muramatsu M (1987) Structure and expression of a human class pi glutathione S-transferase messenger RNA. Cancer Res 475:5626-5630
9. Morrow CS, Cowan KH, Goldsmith ME (1989) Structure of the human genomic glutathione S-transferase-pi gene. Gene 75:3-11. doi: 10.1016/ 0378-1119(89)90377-6
10. Ali-Osman F, Akande O, Antoun G, Mao J, Buolamwini J (1997) Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. J Biol Chem 272:10004-10012. doi: 10.1074/jbc.272.15.10004
11. Board PG, Webb GC, Coggan M (1989) Isolation of a cDNAclone and localization of the human glutathione S-transferase 3 genes to chromosome bands 11q13 and 12q13-14. Ann Hum Genet 53:205-213. doi: 10.1111/j.1469-1809.1989.tb01786.x
12. Miller YE, Fain P (2003) Genetic susceptibility to lung cancer. Semin Respir Crit Care Med 24:197-204. doi: 10.1055/s-2003-39018
13. Hung RJ, Boffetta P, Brockmoller J, Butkiewicz D, Cascorbi I, Clapper ML, Garte S, Haugen A, Hirvonen A, Anttila S, Kalina I, Le Marchand L, London SJ, Rannug A, Romkes M, Salagovic J, Schoket B, Gaspari L, Taioli E (2003) CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: A pooled analysis. Carcinogenesis 24:875-882. doi: 10.1093/carcin/bgg026
14. Shi X, Zhou S, Wang Z, Zhou Z, Wang Z (2008) CYP1A1 and GSTM1 polymorphisms and lung cancer risk in Chinese populations: A meta-analysis. Lung Cancer 59:155-163. doi: 10.1016/j.lungcan.2007.08.004
15. Shah PP, Singh AP, Singh M, Mathur N, Pant MC, Mishra BN, Parmar D (2008) Interaction of cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer. Mutat Res 639:1-10. doi: 10.1016/j.mrfmmm.2007.10.006
16. Cascorbi I, Brockmoller J, Roots I (1996) A C4887A polymorphism in exon 7 of human CYP1A1: Population frequency, mutation linkages, and impact on lung cancer susceptibility. Cancer Res 56:4965-4969
17. Taioli E, Crofts F, Trachman J, Demopoulos R, Toniolo P, Garte SJ (1995) A specific African-American CYP1A1 polymorphism is associated with adenocarcinoma of the lung. Cancer Res 55:472-473
18. Alexandrie AK, Nyberg F, Warholm M, Rannug A (2004) Influence of CYP1A1, GSTM1, GSTT1, and NQO1 genotypes and cumulative smoking dose on lung cancer risk in a Swedish population. Cancer Epidemiol Biomarkers Prev 13:908-914
19. Ng DP, Tan KW, Zhao B, Seow A (2005) CYP1A1 polymorphisms and risk of lung cancer in non-smoking Chinese women: Influence of 15 environmental tobacco smoke exposure and GSTM1/T1 genetic variation. Cancer Causes Control 16:399-405. doi: 10.1007/s10552-004-5476-0
20. Vineis P, Veglia F, Anttila S, Benhamou S, Clapper ML, Dolzan V, Ryberg D, Taioli E (2004) CYP1A1, GSTM1 and GSTT1 polymorphisms and lung cancer: A pooled analysis of gene-gene interactions. Biomarkers 9:298-305. doi: 10.1080/13547500400011070
21. Sobti RC, Sharma S, Joshi A, Jindal SK, Janmeja A (2004) Genetic polymorphism of the CYP1A1, CYP2E1, GSTM1 and GSTT1 genes and lung cancer susceptibility in a north Indian population. Mol Cell Biochem 26:1-9. doi: 10.1023/B:MCBI.0000049127.33458.87
22. Oyama T, Mitsudomi T, Kawamoto T, Osaki T, Kodama Y, Yasumoto K (1995) Detection of CYP1A1 gene polymorphism using designed RFLP and distributions of CYP1A1 genotypes in Japanese. Int Arch Occup Environ Health 67:253-256. doi: 10.1007/BF00409407
23. Basham VM, Pharoah PDP, Healey CS, Luben RN, Day E, Easton DF, Ponder BAJ, Dunning AM (2001) Polymorphism in CYP1A1 and smoking: No association with breast cancer risk. Carcinogenesis 22:1797-1800. doi: 10.1093/carcin/22.11.1797
24. Abdel-Rehman SZ, El-Zein RA, Anwar WA, Au WW (1996) A multiplex PCR procedure for polymorphic analysis of GSTM1 and GSTT1 gene in population studies. Cancer Lett 107:229-233. doi: 10.1016/0304-3835(96)04832-X
25. Harries LW, Stubbins MJ, Forman D, Howard GC, Wolf CR (1997) Identification of genetic polymorphism at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostrate cancer. Carcinogenesis 18:641-644. doi: 10.1093/carcin/18.4.641
26. Garte S, Gaspari L, Alexandrie AK, Ambrosome C, Autrup H, Taioli E (2001) Metabolic gene polymorphism frequencies in control population. Cancer Epidemiol Biomarkers Prev 10:1239-1248
27. Abdel-Rahman SZ, Anwar WA, Abdel-Aal WE, Mostafa HM, Au WW (1998) GSTM1 and GSTT1 genes are potential risk modifiers for bladder cancer. Cancer Detect Prev 22:129-138. doi: 10.1046/j.1525-1500.1998.00934.x
28. Ghosh P, Basu A, Mahata J, Basu S, Sengupta M, Das JK, Mukherjee A, Sarkar AK, Mondal L, Ray K, Giri AK (2006) Cytogenetic damage and genetic variants in the individuals susceptible to arsenic-induced cancer through drinking water. Int J Cancer 118:2470-2480. doi: 10.1002/ ijc.21640
29. Vettriselvi V, Vijayalakshmi K, Paul SF, Venkatachalam P (2006) Genetic variation of GSTM1, GSTT1 and GSTP1 genes in a South Indian population. Asian Pac J Cancer Prev 7:325-328
30. Jain M, Kumar S, Rastogi N, Lal P, Ghoshal UC, Mittal B (2006) GSTT1, GSTM1, and GSTP1 genetic polymorphisms and interaction with tobacco, alcohol and occupational exposure in esophageal cancer patients from North India. Cancer Lett 24:60-67. doi: 10.1016/j.canlet.2005.10.034
31. Mishra DK, Kumar A, Srivastava DS, Mittal RD (2004) Allelic variation of GSTT1, GSTM1 & GSTP1 genes in North Indian population. Asian Pac J Cancer Prev 5:362-365
32. Naveen AT, Adithan C, Padmaja N, Shashindran CH, Abraham BK, Satyanarayanamoorthy K, Anitha P, Gerard N, Krishnamoorthy R (2004) Glutathione S-transferase M1 and T1 null genotype distribution in South Indians. Eur J Clin Pharmacol 60:403-406. doi: 10.1007/s00228-004-0779-3
33. Benhamou S, Lee WJ, Alexandrie AK, Bofetta P, Bouchardy C, Butkiewicz D et al (2002) Meta-and pooled analyses of the effect of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk. Carcinogenesis 23:1334-1350. doi: 10.1093/carcin/23.8.1343
34. To-Figueras J, Gene M, Gomez-Catalan J, Galan MC, Fuentes M, Ramon JM et al (1997) Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) polymorphisms and lung cancer risk among Northwestern Mediterraneans. Carcinogenesis 18:1529-1533. doi: 10.1093/carcin/18.8.1529
35. Lewis SJ, Cherry NM, Niven RML, Barber PV, Povey AC (2002) GSTM1, GSTT1 and GSTP1 polymorphisms and lung cancer risk. Cancer Lett 180:165-171. doi: 10.1016/S0304-3835(02)00028-9
36. Stucker I, Hirvonen A, de Waziers I, Cabelguenne A, Mitrunen K, Cenee S et al (2002) Genetic polymorphisms of glutathione S-transferases as modulators of lung cancer susceptibility. Carcinogenesis 23:1475-1481. doi: 10.1093/carcin/23.9.1475
37. Harris MJ, Coggan M, Langton L, Wilson SR, Board PG (1998) Polymorphism of the Pi class glutathione S-transferase in normal populations and cancer patients. Pharmacogenetics 8:27-31. doi: 10.1097/ 00008571-199802000-00004
38. Jourenkova-Mironova N, Wikman H, Bouchardy C, Voho A, Dayer P, Benhamou S (1998) Role of glutathione S-transferase GSTM1, GSTM3, GSTP1 and GSTT1 genotypes in modulating susceptibility to smoking-related lung cancer. Pharmacogenetics 8:495-502. doi: 10.1097/00008571-199812000-00006
39. Saarikoski T, Voho A, Reinikainen M, Antilla S, Karjalainen A, Malaveille C et al (1998) Combined effect of polymorphic GST genes on individual susceptibility to lung cancer. Int J Cancer 77:516-521. doi:10.1002/(SICI)1097-0215(19980812)77:4<516::AID-IJC7>3.0.CO;2-X
40. Sugimura H, Wakai K, Genka K, Nagura K, Igarashi H, Nagayama K et al (1998) Association of Ile462 Val (Exon 7) polymorphism of cytochrome P450 IA1 with lung cancer in the Asian population: Further evidence from a case-control study in Okinawa. Cancer Epidemiol Biomarkers Prev 7:413-417
41. Bartsch H, Nair U, Risch A, Rojas M, Wikman H, Alexandrov K (2000) Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev 9:3-28
42. Le Marchand L, Guo C, Benhamou S, Bouchardy C, Cascorbi I, Clapper ML et al (2001) Pooled analysis of the CYP1A1 exon 7 polymorphism and lung cancer (United States). Cancer Causes Control 14:339-346. doi: 10.1023/ A:1023956201228
43. London SJ, Yuan JM, Coetzee GA, Gao YT, Ross RK, Yu MC (2000) CYP1A1 I462V genetic polymorphism and lung cancer risk in a cohort of men in Shanghai, China. Cancer Epidemiol Biomarkers Prev 9:987-991
44. Song N, Tan W, Xing D, Lin D (2001) CYP 1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: A case control study in China. Carcinogenesis 22:11-16. doi: 10.1093/carcin/22.1.11
45. Sreeja L, Syamala V, Hariharan S, Madhavan J, Devan SC, Ankathil R (2005) Possible risk modification by CYP1A1, GSTM1 and GSTT1 gene polymorphisms in lung cancer susceptibility in a South Indian population. J Hum Genet 50:618-627. doi: 10.1007/s10038-005-0303-3